In a recent study published in The Lancet Infectious Diseases, scientists reviewed the history of using human challenge trials in developing vaccines. The study explored vaccine development for 19 ...
Respiratory syncytial virus (RSV) remains one of the most significant viral threats across age groups, contributing to substantial morbidity in infants, older adults, and those with underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results